New Mediator Of Smoking Recruits

Main Category: Smoking / Quit Smoking
Also Included In: Lung Cancer;  Heart Disease
Article Date: 27 Apr 2009 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 stars

3 (1 votes)

Healthcare Prof:not yet rated


Current research suggests that smoking increases the production of osteopontin in the lungs, which contributes to the development of smoking-related lung disease. The related report by Prasse et al, "Essential role of osteopontin in smoking-related interstitial lung diseases," appears in the May 2009 issue of The American Journal of Pathology.

Nearly one billion people worldwide smoke tobacco products. Long-term exposure to compounds found in smoke can lead to both cardiovascular and lung disease. Although lung exposure to cigarette smoke leads to immune cell recruitment and tissue fibrosis, how cigarette smoke causes these changes is largely unknown.

To determine if osteopontin, a molecule that attracts immune cells, mediates cell recruitment in smokers, Prasse et al compared osteopontin levels from smokers with different types of lung diseases, healthy smokers, and healthy non-smokers. They found high levels of osteopontin expression in patients with interstitial lung disease, whereas healthy smokers had lower levels, and healthy non-smokers produced no osteopontin. Osteopontin expression could be stimulated directly by nicotine treatment. In addition, expressing osteopontin in rat lung resulted in recruitment of immune cells, resulting in symptoms similar to smoking-related interstitial lung diseases. These results indicate that osteopontin may be pathogenic in smoking-initiated lung disease.

The article from Prasse et al "suggest[s] that chronic nicotine stimulation induced by cigarette smoking promotes macrophage and Langerhans cell accumulation in the lung via an increase in [osteopontin production]." Osteopontin and cellular receptors for nicotine may therefore be new targets for treating smoking related lung disease.

Prasse A, Stahl M, Schulz G, Kayser G, Qang L, Ask K, Yalcintepe J, Kirschbaum A, Bargagli E, Zissel G, Kolb M, Müller-Quernheim J, Weiss JM, Renkl AC: Essential role of osteopontin in smoking-related interstitial lung diseases. Am J Pathol 2009 174: 1683-1691

Source:
Angela Colmone
American Journal of Pathology

Article adapted by Medical News Today from original press release.
Visit our smoking / quit smoking section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Angela Colmone. "New Mediator Of Smoking Recruits." Medical News Today. MediLexicon, Intl., 27 Apr. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/147516.php>

APA
Angela Colmone. (2009, April 27). "New Mediator Of Smoking Recruits." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/147516.php.

Please note: If no author information is provided, the source is cited instead.


Smoking / Quit Smoking

Why Is Smoking Bad For You?

Smoking is responsible for several diseases, such as cancer, long-term (chronic) respiratory diseases, and heart disease, as well as premature death. Over 440,000 people in the USA and 100,000 in the UK die because of smoking each year. Read more...

How To Give Up Smoking

There are many different ways to quit smoking. Some experts advocate using pharmacological products to help wean you off nicotine, others say all you need is a good counselor and support group, or an organized program. Read more...

Most Popular Articles



Follow Our Smoking News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Smoking / Quit Smoking Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »